Patent details

EP3191120 Title: USE OF IL-17 ANTAGONISTS TO INHIBIT THE PROGRESSION OF STRUCTURAL DAMAGE IN PSORIATIC ARTHRITIS PATIENTS

Basic Information

Publication number:
EP3191120
PCT Application Number:
IB2015056871
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP157675976
PCT Publication Number:
WO2016038538
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF IL-17 ANTAGONISTS TO INHIBIT THE PROGRESSION OF STRUCTURAL DAMAGE IN PSORIATIC ARTHRITIS PATIENTS
French Title of Invention:
UTILISATION D'ANTAGONISTES D'IL-17 POUR INHIBER LA PROGRESSION D'UNE LÉSION STRUCTURELLE CHEZ DES PATIENTS ATTEINTS D'UNE POLYARTHRITE PSORIASIQUE
German Title of Invention:
VERWENDUNG VON IL-17 ANTAGONISTEN ZUR HEMMUNG DER PROGRESSION VON STRUKTURSCHÄDEN BEI PATIENTEN MIT PSORIATISCHER ARTHRITIS
SPC Number:

Dates

Filing date:
08/09/2015
Grant date:
10/04/2024
EP Publication Date:
19/07/2017
PCT Publication Date:
17/03/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/04/2024
EP B1 Publication Date:
10/04/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
08/09/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/04/2024
 
 

Name:
NOVARTIS AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
03/07/2024
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
MPOFU, Shephard
Address:
Switzerland (CH)

2

Name:
LIGOZIO, Gregory
Address:
United States (US)

3

Name:
RICHARDS, Hanno
Address:
Switzerland (CH)

Priority

Priority Number:
201462048512 P
Priority Date:
10/09/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/00; C07K 16/24;

Publication

European Patent Bulletin

1

Issue number:
202415
Publication date:
10/04/2024
Description:
Grant (B1)

2

Issue number:
202420
Publication date:
15/05/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/09/2025
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/08/2024
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages
01/07/2024 Power Of Attorney 1
03/07/2024 Outgoing Correspondence 1